The rationale for development of ligelizumab in food allergy

MLA

Robert A. Wood, Md, et al. “The Rationale for Development of Ligelizumab in Food Allergy.” World Allergy Organization Journal, vol. 15, no. 9, Sept. 2022. EBSCOhost, https://doi.org/10.1016/j.waojou.2022.100690.

APA

Robert A. Wood, M., R. Sharon Chinthrajah, M., Alexander Eggel, P., Ivan Bottoli, M., Aurelie Gautier, Ms., Maximilian Woisetschlaeger, P., Paolo Tassinari, Ms., & Pablo Altman, M. (2022). The rationale for development of ligelizumab in food allergy. World Allergy Organization Journal, 15(9). https://doi.org/10.1016/j.waojou.2022.100690

Chicago

Robert A. Wood, Md, Md R. Sharon Chinthrajah, PhD Alexander Eggel, Md Ivan Bottoli, Msc Aurelie Gautier, PhD Maximilian Woisetschlaeger, Msc Paolo Tassinari, and Md Pablo Altman. 2022. “The Rationale for Development of Ligelizumab in Food Allergy.” World Allergy Organization Journal 15 (9). doi:10.1016/j.waojou.2022.100690.